In agreement, a recent systematic review and meta-analysis has pointed out that renin angiotensin system inhibitor treatment, including the angiotensin converting enzyme inhibitor, significantly reduced short- and long-term mortality in AS patients who underwent aortic valvar replacement, but it was also safe for patients with AS who did not undergo valve replacement and did not increase mortality [42]. Here, ACE is linked to aortic stenosis.